V
GILD icon

VeraBank’s Gilead Sciences GILD Stock Holding History

VeraBank’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Sell
2,797
-771
-22% -$102K 0.06% 137
2026
Q1 		$497K Sell
3,568
-164
-4% -$23K 0.09% 117
2025
Q4 		$458K Sell
3,732
-12
-0.3% -$1.46K 0.08% 127
2025
Q3 		$416K Buy
3,744
+161
+4% +$18.3K 0.08% 133
2025
Q2 		$397K Buy
+3,583
New +$381K 0.08% 136

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VeraBank's GILD Position: Q2 2026 in Review

VeraBank reduced its Gilead Sciences (GILD) stake by 22% in Q2 2026, selling an estimated $102K and leaving 2,797 shares worth $353K. The position accounts for 0.06% of the portfolio, ranked #137.

VeraBank first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $497K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • VeraBank held 2,797 shares of Gilead Sciences worth $353K as of Q2 2026.
  • VeraBank sold 771 Gilead Sciences shares in Q2 2026, an estimated $102K.
  • Gilead Sciences made up 0.06% of VeraBank's portfolio in Q2 2026, its #137 holding.
  • VeraBank first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • VeraBank's Gilead Sciences position peaked at $497K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on VeraBank's 13F filing for Q2 2026, filed 6 Aug 2026.